Sarepta Therapeutics Inc
SRPT21.245USD
+0.205+0.97%
Market hours （ET）Quotes delayed by 15 min
2.23BMarket Cap
LossP/E TTM
Sarepta Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
1.90B
52.97%
EPS(YoY)
2.47
142.65%
Analyst Rating
HOLD
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its total revenue reached 1.90B, with a year-on-year change of 52.97%.
What is the Earnings Per Share (EPS) of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 2.474, with a year-on-year change of 142.65%.
What is the net income of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its net income was 235.24M, with a year-on-year change of 143.89%.
What is the net margin of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its net profit margin was 12.37%, with a year-on-year change of 128.69%.
What is the gross margin of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its gross margin was 83.10%, with a year-on-year change of -5.34%.
What is the debt-to-asset ratio of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 28.69%, with a year-on-year change of -24.34%.
What is the Return on Equity (ROE) of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was 19.71%, with a year-on-year change of 122.88%.
What is the Return on Assets (ROA) of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was 6.51%, with a year-on-year change of 138.82%.
What is the operating profit of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its operating profit was 218.08M, with a year-on-year change of 181.43%.
What are the current assets of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its current assets were 3.07B, with a year-on-year change of 19.16%.
What are the total assets of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its total assets of Sarepta Therapeutics Inc were 3.96B, with a year-on-year change of 21.40%.
What are the total liabilities of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its total liabilities of Sarepta Therapeutics Inc were 2.44B, with a year-on-year change of 1.26%.
What is the total equity of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its total equity of Sarepta Therapeutics Inc was 1.53B, with a year-on-year change of 77.78%.
What is the net operating income of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its net operating income of Sarepta Therapeutics Inc was 235.24M, with a year-on-year change of 143.89%.
What is the net investment of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its net investment of Sarepta Therapeutics Inc was 755.56M, with a year-on-year change of 555.70%.
What is the net financing of Sarepta Therapeutics Inc?
According to Sarepta Therapeutics Inc's FY2024 earnings report, its net financing of Sarepta Therapeutics Inc was 124.81M, with a year-on-year change of -0.16%.
